These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21596126)

  • 1. Preparation of polymeric nanoparticles of cyclosporin A using infrared pulsed laser.
    Takebe G; Takagi T; Suzuki M; Hiramatsu M
    Int J Pharm; 2011 Jul; 414(1-2):244-50. PubMed ID: 21596126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel preparation of solid lipid nanoparticles with cyclosporin A for prolonged drug release.
    Hu FQ; Wu MZh; Yuan H; Zhang HH
    Pharmazie; 2004 Sep; 59(9):683-5. PubMed ID: 15497749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of drug-loaded polymeric nanoparticles and evaluation of the antioxidant activity against lipid peroxidation.
    Pohlmann AR; Schaffazick SR; Creczynski-Pasa TB; Guterres SS
    Methods Mol Biol; 2010; 610():109-21. PubMed ID: 20013175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of polymeric pH-sensitive STEALTH® nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel.
    Lundberg BB
    Int J Pharm; 2011 Apr; 408(1-2):208-12. PubMed ID: 21296135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS; Ng ML; Kho K; Hadinoto K
    Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
    Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
    Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling drug nanoparticle formation by rapid precipitation.
    D'Addio SM; Prud'homme RK
    Adv Drug Deliv Rev; 2011 May; 63(6):417-26. PubMed ID: 21565233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
    Derakhshandeh K; Erfan M; Dadashzadeh S
    Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide.
    Singh SK; Srinivasan KK; Gowthamarajan K; Singare DS; Prakash D; Gaikwad NB
    Eur J Pharm Biopharm; 2011 Aug; 78(3):441-6. PubMed ID: 21439378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining SEM, TEM, and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix.
    Karavas E; Georgarakis M; Docoslis A; Bikiaris D
    Int J Pharm; 2007 Aug; 340(1-2):76-83. PubMed ID: 17478064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
    Gaumet M; Vargas A; Gurny R; Delie F
    Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle formation from probucol/PVP/sodium alkyl sulfate co-ground mixture.
    Wanawongthai C; Pongpeerapat A; Higashi K; Tozuka Y; Moribe K; Yamamoto K
    Int J Pharm; 2009 Jul; 376(1-2):169-75. PubMed ID: 19409462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High celecoxib-loaded nanoparticles prepared by a vibrating nozzle device.
    Zvonar A; Kristl J; Kerc J; Grabnar PA
    J Microencapsul; 2009 Dec; 26(8):748-59. PubMed ID: 19888883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrospray technique for solid lipid-based particle production.
    Trotta M; Cavalli R; Trotta C; Bussano R; Costa L
    Drug Dev Ind Pharm; 2010 Apr; 36(4):431-8. PubMed ID: 19788405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
    Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
    Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryogenic liquids, nanoparticles, and microencapsulation.
    Purvis T; Vaughn JM; Rogers TL; Chen X; Overhoff KA; Sinswat P; Hu J; McConville JT; Johnston KP; Williams RO
    Int J Pharm; 2006 Oct; 324(1):43-50. PubMed ID: 16814968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.